Year in Review: New Zealand is controlling medicines expenditure over time

The graph below shows PHARMAC's impact on New Zealand's medicines spending over the past decade using 2010 medicine prices as a baseline.

PHARMAC has avoided $9.3 billion in net medicine costs, with the gap between estimated expenditure (green line) and actual expenditure (blue line) highlighting how much money the health system would have had to spend on medicines if PHARMAC wasn't working hard to manage the costs.